Skip to content
Main Menu
Utah Attorney General
Search
Attorney General
Sean D. Reyes
Utah Office of the Attorney General
Secondary Navigation

AG Reyes Joins Bipartisan Coalition in Calling for Fentanyl Knock-offs to Remain a Schedule I Drug

FOR IMMEDIATE RELEASE
December 12, 2019

UTAH ATTORNEY GENERAL SEAN D. REYES JOINS BIPARTISAN COALITION IN CALLING FOR FENTANYL KNOCK-OFFS TO REMAIN A SCHEDULE I DRUG
All 56 Attorneys General Support and Agree
 

WASHINGTON, D.C. – Utah Attorney General Sean D. Reyes has joined a bipartisan coalition of all 56 attorneys general in calling for Congress to permanently classify fentanyl-related substances as Schedule I drugs.

Schedule I drugs are defined as drugs with no currently accepted medical use and a high potential for abuse.
 
“We’ve got to do everything we can to stop the catastrophic and accelerating abuse of Fentanyl-related substances and its family of opioids,” said Utah Attorney General Sean D. Reyes. “Make no mistake: This is a national crisis. The legitimate use of these drugs has dwindled even as abuse and deaths grow. I urge Congress to pass this legislation as soon as possible.”

In the letter, the attorneys general urge Congress to pass S. 2701, the Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act, a bipartisan bill introduced by U.S. Senators Rob Portman (R-OH) and Joe Manchin (D-WV).

The Drug Enforcement Administration (DEA) issued a temporary scheduling order in February 2018 to schedule fentanyl-related substances that has allowed federal law enforcement authorities to bring criminal actions against individuals who manufacture, distribute or handle fentanyl-related substances.

This scheduling order is set to expire less than two months from now on Feb. 6, 2020. The FIGHT Fentanyl Act codifies DEA precedent to schedule fentanyl-related substances.

The FIGHT Fentanyl Act will ensure law enforcement agencies and courts retain the tools needed to keep those who traffic in this deadly substance off the streets.

In the most recent data available from the Centers for Disease Control and Prevention, there were 72,000 drug-related deaths in the United States in 2017. Of those deaths, roughly 40% involved fentanyl or a fentanyl-related compound.

Attorneys general from every state, territory and the District of Columbia signed the letter.
 

###

Utah Opioid Task Force Convenes, Says Farewell to DEA District-Agent-in-Charge Brian Besser

November 25, 2019

Today, the Utah Opioid Task Force convened to discuss the opioid crisis in Utah and to consider new programs and resources.

Miss it? Listen to the audio here:

Trauma and Suicide Screening and Response

Dr. Brooks Keeshin with the University of Utah and Primary Children’s Hospital presented on the link between childhood trauma, suicide, and substance abuse. Keeshin has been working with the Children’s Justice Centers to help screen children at risk and get them the resources they need.

The Appropriate Use of the DEC Exam

Dr. Toni Laskey with the University of Utah and Primary Children’s Hospital presented on her work to create more effective medical exams and care for drug endangered children.

Sober Peer

Ed DeShields presented on Sober Peer, an upcoming app for those struggling with addiction, powered by an artificial intelligence-driven system that measures recovery, predicts outcomes, and suggests “best”, next steps for treatment.

For more information: soberpeer.com.

BluNovus

James Hadlock presented on the need for personal connection in the fight against opioid addiction and mental illness. Additionally, he presented on BluNovus, a company that helps employers connect employees to mental health resources and works to end the stigma.

For more information: blunovus.com

Farewell to DEA District-Agent-in-Charge Brian Besser

Utah Attorney General Sean D. Reyes presented an award to DEA District-in-Charge Brian Besser for his incredible work in the fight against the opioid crisis in Utah and in the Opioid Task Force. Besser will head to Washington, D.C. in a new role in the DEA. We congratulate Besser and thank him for all that he has done. He will be dearly missed here, but we look forward to working with him in his new role.